u/hassan_chowdhury

The online consultation asked me three questions, none of them about my history. I did not go ahead.

Did they name the facility?

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

the first person to notice was me, months after it started

Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

Small fix — that is fat-free mass, not muscle mass. The scan cannot separate them the way the post assumes.

Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.

measurements beat photographs for actually tracking anything

Not quite. Two labs with different gradients can resolve a close-eluting impurity differently and both be reporting honestly.

Right — strength retention is a free proxy and it tracks better than most people expect.

nothing on this board is a training or nutrition prescription

Push back: a private prescription is a separate route, not a shortcut through the NHS queue.

My first certificate had a compound name, a percentage and a logo. I thought that was normal. It is not, and now I know what to ask for.

GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.

non-scale victories count and they are the ones people remember

Disagree with the tone strategy.

Adding the underused one — external review. Independent, binding where it applies, and hardly anybody gets that far.

Cosigning. The batch identifier is load-bearing, and a certificate that cannot be tied to the vial in your hand is not about your vial.

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

Agreed — text only was the best rule this board ever adopted. The posts are about what actually changed rather than about lighting.

Careful — "the metadata looks odd" is a reason to ask a question, not a conclusion. Re-issues are ordinary.

Yes — the consultation that asks nothing tells you what kind of service it is.

Agreed — the itemised related substances table is the difference between a document and a receipt.

This. Compounded preparations carry no equivalence claim, and treating them as generics is a category error people make constantly.

Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.

Cosigning on external review. It is a real mechanism, it is underused, and the deadlines are strict.

losing weight slower does not automatically preserve more lean mass

This. The monthly pricing tracker is the most useful thing on this board and it works because nobody is allowed to link anything.

Sent one vial to PeptideMeter and Medutest.

katrin_girard has the distinction right — one is a fraction of the detector signal, the other is a fraction of the mass.

Spent six weeks arguing in general terms and got nowhere. Two paragraphs quoting their own criteria turned it around in eleven days.

the related substances line is where the story is

a total of 0.4% tells you less than four named impurities adding to 0.6%

DEXA has a meaningful coefficient of variation, and it differs between machines and protocols. Comparing scans from different clinics adds a systematic offset that is invisible on the report.

What exactly does the denial letter give as the reason?

Agreed.

This is the whole method. Answer the criterion they named, not the decision in general.

I would not treat a two-kilo range as a regain. Weight varies day to day in everybody.

Water content 3.8%, acetate 6.2%, purity 99%, net peptide about 90% of label weight. All four numbers honest, and I had to read it twice.